Package 50090-5029-0

Brand: invokana

Generic: canagliflozin
NDC Package

Package Facts

Identity

Package NDC 50090-5029-0
Digits Only 5009050290
Product NDC 50090-5029
Product ID 50090-5029_4a627123-1563-4586-9cde-6588413cbb60
Description

90 TABLET, FILM COATED in 1 BOTTLE (50090-5029-0)

Marketing

Marketing Status
Marketed Since 2020-04-28
Brand invokana
Generic canagliflozin
Sample Package No

Linked Drug Pages (1)

INVOKANA ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4a627123-1563-4586-9cde-6588413cbb60", "openfda": {"unii": ["0SAC974Z85"], "rxcui": ["1373471", "1373473"], "spl_set_id": ["4e946ba3-02c4-4a10-9d5e-f2d87b534dc3"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (50090-5029-0)", "package_ndc": "50090-5029-0", "marketing_start_date": "20200428"}], "brand_name": "INVOKANA", "product_id": "50090-5029_4a627123-1563-4586-9cde-6588413cbb60", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["P-Glycoprotein Inhibitors [MoA]", "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "product_ndc": "50090-5029", "generic_name": "canagliflozin", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "INVOKANA", "active_ingredients": [{"name": "CANAGLIFLOZIN", "strength": "300 mg/1"}], "application_number": "NDA204042", "marketing_category": "NDA", "marketing_start_date": "20130329", "listing_expiration_date": "20261231"}